Active Across
40+ Countries.
UK Pharmaceutical Export to GCC, Africa & Europe — MHRA Licensed Wholesale Supplier to 40+ Countries
From our London base, we supply healthcare systems, institutions, and distributors across four major global regions - wherever medicine is needed and conventional supply can't reach.
Discuss Your Region →We have active supply relationships and regulatory familiarity across these four regions.
Our UK base gives us established access to European markets, with strong familiarity with post-Brexit import/export regulatory frameworks. We supply UK NHS institutions directly and serve European healthcare buyers requiring UK-sourced or internationally-sourced medicines.
Europe supply details →The GCC and wider MENA region represents a significant part of our active network. We have experience supplying hospitals, government procurement bodies, and private healthcare groups across the Gulf states and broader Middle East, navigating local registration and import requirements.
GCC supply details →Sub-Saharan and North Africa represent some of the most complex pharmaceutical supply environments globally - high demand, regulatory variation, and significant NGO and government procurement activity. We are experienced in navigating these markets and supporting aid and development organisations operating across the continent.
Africa supply details →The Commonwealth of Independent States and South/Central Asia are regions where demand for speciality and unlicensed medicines is high. We serve distributors, healthcare institutions, and government buyers in these markets - managing the regulatory and logistics complexity that comes with these supply routes.
CIS & Asia supply details →Euro Biom supplies branded, generic and unlicensed medicines to hospitals, health ministries, distributors and NGOs across Sub-Saharan and North Africa. All products are sourced from licensed UK suppliers, handled under GDP, and shipped via air freight from our Heathrow base with full export documentation.
We work with both private healthcare buyers and institutional procurement bodies - including government health ministries and international NGOs operating medicine programmes across the continent. For procurement teams conducting supplier qualification, we provide our MHRA WDA certificate, GDP records, and full chain of custody documentation on request.
We can supply medicines not locally registered or available through standard regional channels. Our MHRA authorisation covers unlicensed medicine supply, providing the regulatory basis and documentation needed to support importation under special import or compassionate use frameworks in African markets.
Africa Supply Credentials
Euro Biom supplies branded, generic and unlicensed medicines to hospitals, health ministries, licensed distributors and specialist clinics across the Gulf Cooperation Council and wider Middle East. All supply is GDP-compliant and supported by full UK export documentation tailored to the requirements of GCC health authorities.
For GCC procurement teams, we provide MHRA WDA certificates, GDP compliance records, certificates of pharmaceutical product (CPP), batch analysis reports, and chain of custody documentation aligned with SFDA, UAE MoH, QCHEM and other regional regulatory body requirements. We are experienced in both private healthcare and government institutional procurement across the region.
Many medicines required by GCC specialist hospitals are not locally registered. We are MHRA-authorised to supply unlicensed medicines, providing the regulatory documentation needed to support importation under compassionate use or special import frameworks in GCC markets.
GCC Supply Credentials
Euro Biom supplies branded, generic and unlicensed medicines to hospitals, health systems, importers and specialist distributors across Europe. Our UK base and MHRA Wholesale Dealer Authorisation provide the regulatory credibility and supply chain transparency that European procurement teams require.
Post-Brexit regulatory divergence has created new demand for UK-sourced medicines in EU markets - particularly for products subject to supply shortages, parallel distribution, or named-patient import frameworks. We navigate these complexities daily, providing full documentation aligned to the importing country's regulatory requirements.
For European healthcare buyers, we provide MHRA WDA certificates, GDP compliance records, certificates of pharmaceutical product (CPP), and complete chain of custody documentation. Our Heathrow location enables next-day delivery to most European destinations.
Europe Supply Credentials
Euro Biom supplies branded, generic and unlicensed medicines to hospitals, oncology centres, licensed importers and ministry-of-health procurement bodies across the Commonwealth of Independent States. All supply is GDP-compliant, UK-sourced and supported by the full documentation package required by regulators such as NCEMD Kazakhstan, Uzpharmagentlik, AEC Azerbaijan, RAMPA Georgia and SCDMTE Armenia.
For CIS procurement teams we provide MHRA WDA(H) 59239 certificates, GDP compliance records, certificates of pharmaceutical product (CPP), batch analysis reports, notarised and apostilled export paperwork, and chain-of-custody documentation aligned to each country's special-import or named-patient pathway. We are experienced with both tender-based public procurement and private clinic supply.
Many specialist oncology, haematology and rare-disease medicines required by CIS hospitals are not locally registered. Our MHRA authorisation covers unlicensed medicine supply, providing the regulatory basis needed to support importation under the special-import frameworks that operate across the CIS region.
CIS Supply Credentials
Euro Biom supplies branded, generic and unlicensed medicines to hospitals, tertiary care centres, licensed importers and government procurement bodies across South Asia and Southeast Asia. All supply is MHRA-authorised, GDP-compliant and UK-sourced, with export documentation tailored to each country's special-import or named-patient framework.
For Asian procurement teams we routinely prepare documentation aligned to CDSCO Rule 36 (India), DRAP Form-6 (Pakistan), DGDA NOC (Bangladesh), NMRA waivers (Sri Lanka), Thai FDA Section 13(2), DAV Circular 32 (Vietnam), BPOM SAS (Indonesia), NPRA (Malaysia), FDA Philippines CSP and HSA NPS (Singapore). We support both hospital named-patient cases and longer-term institutional supply programmes.
Many oncology, rare-disease and specialist medicines required by Asian tertiary hospitals are not locally registered. Our MHRA authorisation covers unlicensed medicine supply, providing the CPPs, batch records and chain-of-custody documentation needed to support importation under each market's special-access route.
Asia Supply Credentials
for Global Export
Our location at Harmondsworth, London - adjacent to Heathrow Airport - is no accident. It positions us at the heart of one of the world's busiest international freight hubs, enabling fast, reliable global dispatch.
Being UK-based and MHRA-licensed also means our products carry the credibility of UK regulatory oversight - recognised and trusted by procurement authorities and healthcare institutions worldwide.
Operating in Your Region?
Tell us your country and requirement - we'll confirm our capability and respond promptly.